Search tips
Search criteria 


Logo of procrsmedFormerly medchtJournal of the Royal Society of MedicineProceedings of the Royal Society of Medicine
Proc R Soc Med. 1963 March; 56(3): 179–182.
PMCID: PMC1897332

Serum Enzymes in Clinical Practice

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (602K), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • CHUNG CS, MORTON NE, PETERS HA. Serum enzymes and genetic carriers in muscular dystrophy. Am J Hum Genet. 1960 Mar;12:52–66. [PubMed]
  • DREYFUS JC, SCHAPIRA G, DEMOS J. [Study of serum creatine kinase in myopathic patients and their families]. Rev Fr Etud Clin Biol. 1960 Apr;5:384–386. [PubMed]
  • DREYFUS JC, SCHAPIRA G, SCHAPIRA F. Serum enzymes in the physiopathology of muscle. Ann N Y Acad Sci. 1958 Oct 13;75(1):235–249. [PubMed]
  • BAKER RW, EVANS JH. Serum aldolase and the diagnosis of myopathy. Brain. 1957 Dec;80(4):557–570. [PubMed]
  • FRIEDMAN MM, LAPAN B. Serum aldolase in the neonatal period: including a colorimetric determination of aldolase by standardization with dihydroxyacetone. J Lab Clin Med. 1958 May;51(5):745–752. [PubMed]
  • HUGHES BP. A method for the estimation of serum creatine kinase and its use in comparing creatine kinase and aldolase activity in normal and pathological sera. Clin Chim Acta. 1962 Sep;7:597–603. [PubMed]
  • OLIVER IT. A spectrophotometric method for the determination of creatine phosphokinase and myokinase. Biochem J. 1955 Sep;61(1):116–122. [PubMed]
  • PEARSON CM, CHOWDHURY SR, FOWLER WM, Jr, JONES MH, GRIFFITH WH. Studies of enzymes in serum in muscular dystrophy. II. Diagnostic and prognostic significance in relatives of dystrophic persons. Pediatrics. 1961 Dec;28:962–970. [PubMed]
  • SOLVONUK PF, MCRAE SC, COLLIER HB. Creatine phosphokinase activity of mammalian erythrocytes. Can J Biochem Physiol. 1956 May;34(3):481–487. [PubMed]
  • TANZER ML, GILVARG C. Creatine and creatine kinase measurement. J Biol Chem. 1959 Dec;234:3201–3204. [PubMed]
  • THOMPSON RA, VIGNOS PJ., Jr Serum aldolase in muscle disease. AMA Arch Intern Med. 1959 Apr;103(4):551–564. [PubMed]
  • THOMSON WA. Sources of error in the biochemical diagnosis of muscular dystrophy. J Neurol Neurosurg Psychiatry. 1962 Aug;25:191–202. [PMC free article] [PubMed]
  • THOMSON WH, LEYBURN P, WALTON JN. Serum enzyme activity in muscular dystrophy. Br Med J. 1960 Oct 29;2(5208):1276–1281. [PMC free article] [PubMed]
  • VIGNOS PJ, Jr, LEFKOWITZ M. A biochemical study of certain skeletal muscle constituents in human progressive muscular dystrophy. J Clin Invest. 1959 Jun;38(6):873–881. [PMC free article] [PubMed]
  • ZIERLER KL. Diffusion of aldolase from rat skeletal muscle; an index of membrane permeability. Am J Physiol. 1957 Aug;190(2):201–205. [PubMed]

Articles from Proceedings of the Royal Society of Medicine are provided here courtesy of Royal Society of Medicine Press